Skip to main content

SLC13A5 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-85736

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-85736-0.1ml

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the middle region of Human SLC13A5. Peptide sequence: CKAMTLCICYAASIGGTATLTGTGPNVVLLGQMNELFPDSKDLVNFASWF The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for SLC13A5 Antibody

Western Blot: SLC13A5 Antibody [NBP2-85736]

Western Blot: SLC13A5 Antibody [NBP2-85736]

Western Blot: SLC13A5 Antibody [NBP2-85736] - Host: Rabbit. Target Name: SLC13A5. Sample Type: Thymus Tumor lysates. Antibody Dilution: 1.0ug/ml

Applications for SLC13A5 Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: SLC13A5

SLC13A5 - solute carrier family 13 (sodium-dependent citrate transporter), member 5

Long Name

Solute carrier family 13 member 5

Alternate Names

NaCT

Gene Symbol

SLC13A5

Additional SLC13A5 Products

Product Documents for SLC13A5 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for SLC13A5 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...